Shawn M. Talbott, Chief Science Officer at Lifevantage Corp (LFVN), bought 2,600 shares at $1.02 ($3K) on 2015-02-17, disclosed to the SEC on 2015-02-20.
Open-market purchase of $3k LFVN by Chief Science Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.